Risperidone for Substance Dependent Psychotic Patients

被引:4
|
作者
Poling, James
Kosten, Thomas R.
机构
[1] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA
[2] VISN 1 Mental Illness Res Educ & Clin Ctr, West Haven, CT USA
来源
关键词
risperidone; substance use disorders; schizophrenia; cannabis; stimulants;
D O I
10.1097/00132576-200503000-00001
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Objective: This study examined urine toxicology results at a single VA clinic in psychotic veterans with substance use disorders before and after switching to risperidone. Methods: In FY1995-2000, 104 psychotic veterans with substance use disorders (SUD) switched to risperidone (0.5-4 mg) and had urine toxicologies (avg 18) documenting opiate, cocaine, or marijuana use for at least 3 months before and after switching. Results: The rate of illicit urines was significantly higher before than after switching to risperidone (38% vs. 29%) (cocaine 19% to 15%; cannabis 13% to 10%). Conclusions: Urine toxicologies in a sample of veterans showed that risperidone was associated with a modest reduction in a range of illicit drugs over a period of 3 months before and after a medication switch.
引用
收藏
页码:1 / 3
页数:3
相关论文
共 50 条
  • [1] Efficacy of risperidone in relapsing psychotic patients
    Rubesa, G
    Peitl, A
    Peitl, MV
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S239 - S239
  • [2] Risperidone in the treatment of elderly patients with psychotic disorders
    Madhusoodanan, S
    Brecher, M
    Brenner, R
    Kasckow, J
    Kunik, M
    Negrón, AE
    Pomara, N
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 1999, 7 (02): : 132 - 138
  • [3] The effect of fluoxetine on the pharmacokinetics and safety of risperidone in psychotic patients
    Bondolfi, G
    Eap, CB
    Bertschy, G
    Zullino, D
    Vermeulen, A
    Baumann, P
    PHARMACOPSYCHIATRY, 2002, 35 (02) : 50 - 56
  • [4] The side effects of risperidone depot in patients with psychotic disorders
    Jupe, T.
    Elezi, F.
    Zenelaj, B.
    Myslimi, E.
    EUROPEAN PSYCHIATRY, 2017, 41 : S816 - S816
  • [5] Metabolic effects of olanzapine and risperidone in patients with psychotic disorders
    Safa, Mitra
    Sadr, Saeed
    Delfan, Bahram
    Saki, Mandana
    Javad Tarrahi, Mohammad
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2008, 12 (04) : 299 - 302
  • [6] Risperidone in the treatment of psychotic patients with opiate abuse and dependence
    Casas, M
    Gutiérrez, M
    Gibert, J
    Bobes, J
    Roncero, C
    Octavio, I
    ACTAS ESPANOLAS DE PSIQUIATRIA, 2001, 29 (06): : 380 - 385
  • [7] The assessment of risperidone, oral solution in acute psychotic patients
    Hirabayashi, E.
    Okada, S.
    Osako, M.
    Fushimi, M.
    Masuya, J.
    Iimori, M.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S272 - S272
  • [8] Efficacy and safety of risperidone in psychotic patients: An open study
    Daradkeh, TK
    Reda, F
    Karim, L
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1996, 24 (03) : 291 - 295
  • [9] Effectiveness of risperidone oral solution for psychotic agitated patients
    Eiichi, Hirabayashi
    Sanae, Okada
    Makio, Iimori
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 77 - 78
  • [10] A comparison of risperidone and olanzapine for the psychotic patients with tardive dyskinesia (TD)
    Chan, HY
    Chen, CH
    Chen, JJ
    Lai, CL
    Sun, HJ
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S428 - S428